Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Biol Ther. 2010 Feb 25;9(3):246–252. doi: 10.4161/cbt.9.3.10751

Figure 2.

Figure 2

The percentage of positive nuclei was calculated for each specimen. All three markers were expressed more strongly with tumor progression. The expression was significantly increased in advanced carcinoma [(A) vs. normal tissue for pATM (B) vs. normal and adenoma for γH2AX (C) vs. normal tissue for pChk2] *p < 0.05.